Patents by Inventor Elodie SCALICI

Elodie SCALICI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods employing circulating DNA and miRNA as biomarkers for female infertility
    Patent number: 10731218
    Abstract: The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods for determining the ovarian reserve and ovarian function by determining the level of cell-free nucleic acids or the level of a miRNA species selected from miR_30_a or miR_140 or let_7_b or miR_191 or miR_320_a or miR_21 or miR_30_d or miR_574_3p. The method may also be used in predicting the efficacy of controlled ovarian hyperstimulation.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: August 4, 2020
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER, CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
    Inventors: Samir Hamamah, Sabine Traver, Elodie Scalici
  • Methods for three dimensional reconstruction and determining the quality of an embryo
    Patent number: 10628944
    Abstract: The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods and devices for determining the quality of an embryo. More specifically, the present invention relates to the use of three dimensional reconstructions for determining the quality of an embryo.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: April 21, 2020
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITE DE MONTPELLIER, CENTRE HOSPITALIER UNIVERSITAIRE DE MONPELLIER
    Inventors: Samir Hamamah, Elodie Scalici
  • METHODS EMPLOYING CIRCULATING DNA AND MIRNA AS BIOMARKERS FOR FEMALE INFERTILITY
    Publication number: 20190367987
    Abstract: The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods for determining the ovarian reserve and ovarian function by determining the level of cell-free nucleic acids or the level of a miRNA species selected from miR_30_a or miR_140 or let_7_b or miR_191 or miR_320_a or miR_21 or miR_30_d or miR_574_3p. The method may also be used in predicting the efficacy of controlled ovarian hyperstimulation.
    Type: Application
    Filed: June 20, 2019
    Publication date: December 5, 2019
    Inventors: Samir HAMAMAH, Sabine TRAVER, Elodie SCALICI
  • Methods employing circulating DNA and miRNA as biomarkers for female infertility
    Patent number: 10400282
    Abstract: The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods for determining the ovarian reserve and ovarian function by determining the level of cell-free nucleic acids or the level of a miRNA species selected from miR_30_a or miR_140 or let_7_b or miR_191 or miR_320_a or miR_21 or miR_30_d or miR_574_3p. The method may also be used in predicting the efficacy of controlled ovarian hyperstimulation.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: September 3, 2019
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉET DE LA RECHERCHE MÉDICALE), UNIVERSITE DE MONTPELLIER, CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
    Inventors: Samir Hamamah, Sabine Traver, Elodie Scalici
  • Free nucleic acids and miRNA as non-invasive method for determining embryo quality
    Patent number: 10184150
    Abstract: The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to in vitro non-invasive methods for determining the quality of an embryo by determining the level of the cell free nucleic acids or miR-29a or let7-b in the nucleic acid extract from a follicular fluid sample.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: January 22, 2019
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITÉ DE MONTPELLIER, CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
    Inventors: Samir Hamamah, Elodie Scalici, Sabine Traver
  • METHODS EMPLOYING CIRCULATING DNA AND MIRNA AS BIOMARKERS FOR FEMALE INFERTILITY
    Publication number: 20170152561
    Abstract: The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods for determining the ovarian reserve and ovarian function by determining the level of cell-free nucleic acids or the level of a miRNA species selected from miR_30_a or miR_140 or let_7_b or miR_191 or miR_320_a or miR_21 or miR_30_d or miR_574_3p. The method may also be used in predicting the efficacy of controlled ovarian hyperstimulation.
    Type: Application
    Filed: June 26, 2015
    Publication date: June 1, 2017
    Inventors: Samir HAMAMAH, Sabine TRAVER, Elodie SCALICI
  • FREE NUCLEIC ACIDS AND MIRNA AS NON-INVASIVE METHOD FOR DETERMINING EMBRYO QUALITY
    Publication number: 20170152557
    Abstract: The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to in vitro non-invasive methods for determining the quality of an embryo by determining the level of the cell free nucleic acids or miR-29a or let7-b in the nucleic acid extract from a follicular fluid sample.
    Type: Application
    Filed: June 26, 2015
    Publication date: June 1, 2017
    Inventors: Samir HAMAMAH, Elodie SCALICI, Sabine TRAVER
  • METHODS FOR THREE DIMENSIONAL RECONSTRUCTION AND DETERMINING THE QUALITY OF AN EMBRYO
    Publication number: 20170140535
    Abstract: The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods and devices for determining the quality of an embryo. More specifically, the present invention relates to the use of three dimensional reconstructions for determining the quality of an embryo.
    Type: Application
    Filed: July 1, 2015
    Publication date: May 18, 2017
    Inventors: Samir HAMAMAH, Elodie SCALICI